Abbott Laboratories (GB:0Q15)
LSE:0Q15
Holding GB:0Q15?
Track your performance easily

Abbott Laboratories (0Q15) Financial Statements

2 Followers

Abbott Laboratories Financial Overview

Abbott Laboratories's market cap is currently ―. The company's EPS TTM is $3.288; its P/E ratio is 35.94; and it has a dividend yield of 1.85%. Abbott Laboratories is scheduled to report earnings on January 22, 2025, and the estimated EPS forecast is $1.34. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 10.63B$ 10.38B$ 9.96B$ 10.24B$ 10.14B
Gross Profit$ 5.94B$ 5.77B$ 5.50B$ 5.68B$ 5.54B
EBIT$ 1.94B$ 1.75B$ 1.58B$ 1.95B$ 1.84B
EBITDA$ 2.74B$ 2.55B$ 2.38B$ 2.77B$ 2.66B
Net Income Common Stockholders$ 1.65B$ 1.30B$ 1.23B$ 1.59B$ 1.44B
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 7.79B$ 7.22B$ 6.65B$ 7.28B$ 7.05B
Total Assets$ 74.36B$ 73.02B$ 72.47B$ 73.21B$ 72.09B
Total Debt$ 14.98B$ 14.75B$ 14.59B$ 14.68B$ 15.53B
Net Debt$ 7.19B$ 7.54B$ 7.93B$ 7.40B$ 8.48B
Total Liabilities$ 34.33B$ 33.46B$ 33.42B$ 34.39B$ 34.40B
Stockholders Equity$ 39.80B$ 39.32B$ 38.81B$ 38.60B$ 37.48B
Cash Flow-
Free Cash Flow$ 2.15B$ 1.43B$ 627.00M$ 2.28B$ 1.32B
Operating Cash Flow$ 2.71B$ 1.96B$ 1.02B$ 3.04B$ 1.88B
Investing Cash Flow$ -594.00M$ -453.00M$ -425.00M$ -824.00M$ -634.00M
Financing Cash Flow$ -1.58B$ -791.00M$ -1.18B$ -2.05B$ -2.34B
Currency in USD

Abbott Laboratories Earnings and Revenue History

Abbott Laboratories Debt to Assets

Abbott Laboratories Cash Flow

Abbott Laboratories Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis